|[September 04, 2013]
Research and Markets: Acute Coronary Syndrome - Pipeline Review, H2 2013
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/xchwg2/acute_coronary)
has announced the addition of the "Acute
Coronary Syndrome - Pipeline Review, H2 2013" report to their
'Acute Coronary Syndrome - Pipeline Review, H2 2013', provides an
overview of the indication's therapeutic pipeline. This report provides
information on the therapeutic development for Acute Coronary Syndrome,
complete with latest updates, and special features on late-stage and
discontinued projects. It also reviews key players involved in the
therapeutic development for Acute Coronary Syndrome.
- A snapshot of the global therapeutic scenario for Acute Coronary
- A reviewof the Acute Coronary Syndrome products under development by
companies and universities/research institutes based on information
derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging
from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and
- Coverage of the Acute Coronary Syndrome pipeline on the basis of route
of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
F. Hoffmann-La Roche Ltd.
Ligand Pharmaceuticals Incorporated
Arena Pharmaceuticals, Inc.
LG Life Sciences, Ltd
Viron Therapeutics, Inc.
Cerenis Therapeutics SA
Lee's Pharmaceutical Holdings Limited
Ampio Pharmaceuticals, Inc.
and many more...
For more information visit http://www.researchandmarkets.com/research/xchwg2/acute_coronary
About Research and Markets
Research and Markets is the world's leading source for international
market research reports and market data. We provide you with the latest
data on international and regional markets, key industries, the top
companies, new products and the latest trends.
[ Back To Technology News's Homepage ]